2023-2029 Global Transdermal Drug Patches Industry Research & Trends Analysis Report
According to Latest Study, the global market for Transdermal Drug Patches should grow from US$ 6831.1 million in 2022 to US$ 7641.6 million by 2029, with a CAGR of 1.9% for the period of 2023-2029.
Global key players of transdermal drug patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, etc. The top five players hold a share about 37%. North America is the largest market, has a share about 50%, followed by Europe and Asia-Pacific, both have a share about 24 percent.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
This report aims to provide a comprehensive study of the global market for Transdermal Drug Patches. Report Highlights:
(1) Global Transdermal Drug Patches market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Transdermal Drug Patches market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Transdermal Drug Patches market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Transdermal Drug Patches segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Transdermal Drug Patches segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Transdermal Drug Patches, capacity, production and trends.
(7) Transdermal Drug Patches industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Market segment by application, can be divided into
Rx Channel
OTC Channel
Market segment by players, this report covers
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories
1 Market Overview
1.1 Transdermal Drug Patches Definition
1.2 Global Transdermal Drug Patches Market Size and Forecast
1.2.1 By Revenue, Global Transdermal Drug Patches Market Size, 2018-2029
1.2.2 By Sales Volume, Global Transdermal Drug Patches Market Size, 2018-2029
1.2.3 Global Transdermal Drug Patches Price Trend, 2018-2029
1.3 China Transdermal Drug Patches Market Size and Forecast
1.3.1 By Revenue, China Transdermal Drug Patches Market Size, 2018-2029
1.3.2 By Sales Volume, China Transdermal Drug Patches Market Size, 2018-2029
1.3.3 China Transdermal Drug Patches Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Transdermal Drug Patches Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Transdermal Drug Patches Share in Global Market, 2018-2029
1.4.3 Transdermal Drug Patches Market Size: China VS Global, 2018-2029
1.5 Transdermal Drug Patches Market Dynamics
1.5.1 Transdermal Drug Patches Market Drivers
1.5.2 Transdermal Drug Patches Market Restraints
1.5.3 Transdermal Drug Patches Industry Trends
1.5.4 Transdermal Drug Patches Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Transdermal Drug Patches Revenue by Company, 2018-2023
2.2 Global Transdermal Drug Patches Sales Volume by Company, 2018-2023
2.3 Global Transdermal Drug Patches Price by Company, 2018-2023
2.4 Global Transdermal Drug Patches Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Transdermal Drug Patches Concentration Ratio
2.6 Global Transdermal Drug Patches Mergers & Acquisitions, Expansion Plans
2.7 Global Transdermal Drug Patches Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Transdermal Drug Patches Revenue by Company, 2018-2023
3.2 China Transdermal Drug Patches Sales Volume by Company, 2018-2023
3.3 China Transdermal Drug Patches Transdermal Drug Patches Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Transdermal Drug Patches Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Transdermal Drug Patches Domestic VS Export
3.6 China Market, Transdermal Drug Patches Import & Export
3.6.1 China Market, Transdermal Drug Patches Import & Export, 2018-2029
3.6.2 China Transdermal Drug Patches Import & Export Trends
3.6.3 Main Sources of China Transdermal Drug Patches Import
3.6.4 Export Destination of China Transdermal Drug Patches
4 Transdermal Drug Patches Production by Region
4.1 Global Transdermal Drug Patches Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Transdermal Drug Patches Manufacturers
4.3 Global Major Manufacturers, Transdermal Drug Patches Capacity Expansion and Future Plans
4.4 Global Transdermal Drug Patches Capacity by Region
4.5 Global Transdermal Drug Patches Production by Region
4.5.1 Global Transdermal Drug Patches Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Transdermal Drug Patches Production by Region, 2018-2023
4.5.3 Global Transdermal Drug Patches Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Transdermal Drug Patches Industry Chain
5.2 Transdermal Drug Patches Upstream Analysis
5.2.1 Transdermal Drug Patches Core Raw Materials
5.2.2 Main Manufacturers of Transdermal Drug Patches Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Transdermal Drug Patches Production Mode
5.6 Transdermal Drug Patches Procurement Model
5.7 Transdermal Drug Patches Industry Sales Model and Sales Channels
5.7.1 Transdermal Drug Patches Sales Model
5.7.2 Transdermal Drug Patches Typical Distributors
6 Sights by Type
6.1 Transdermal Drug Patches Classification
6.1.1 Methyl Salicylate-based Patch
6.1.2 Rivastigmine Transdermal Patch
6.1.3 Fentanyl Transdermal Patch
6.1.4 Lidocaine Patch
6.1.5 Diclofenac Patch
6.1.6 Nicotine Transdermal Patch
6.1.7 Others
6.2 By Type, Global Transdermal Drug Patches Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Transdermal Drug Patches Revenue, 2018-2029
6.4 By Type, Global Transdermal Drug Patches Sales Volume, 2018-2029
6.5 By Type, Global Transdermal Drug Patches Price, 2018-2029
7 Sights by Application
7.1 Transdermal Drug Patches Segment by Application
7.1.1 Rx Channel
7.1.2 OTC Channel
7.2 By Application, Global Transdermal Drug Patches Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Transdermal Drug Patches Revenue, 2018-2029
7.4 By Application, Global Transdermal Drug Patches Sales Volume, 2018-2029
7.5 By Application, Global Transdermal Drug Patches Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Transdermal Drug Patches Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Transdermal Drug Patches Revenue, 2018-2029
8.3 By Region, Global Transdermal Drug Patches Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Transdermal Drug Patches Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Transdermal Drug Patches Market Size Market Share
8.5 Europe
8.5.1 Europe Transdermal Drug Patches Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Transdermal Drug Patches Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Transdermal Drug Patches Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Transdermal Drug Patches Market Size Market Share
8.7 South America
8.7.1 South America Transdermal Drug Patches Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Transdermal Drug Patches Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Transdermal Drug Patches Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Transdermal Drug Patches Revenue, 2018-2029
9.3 By Country, Global Transdermal Drug Patches Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Transdermal Drug Patches Market Size, 2018-2029
9.4.2 By Company, U.S. Transdermal Drug Patches Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Transdermal Drug Patches Market Size, 2018-2029
9.5.2 By Company, Europe Transdermal Drug Patches Sales Volume Market Share, 2022
9.5.3 By Type, Europe Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Transdermal Drug Patches Market Size, 2018-2029
9.6.2 By Company, China Transdermal Drug Patches Sales Volume Market Share, 2022
9.6.3 By Type, China Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Transdermal Drug Patches Market Size, 2018-2029
9.7.2 By Company, Japan Transdermal Drug Patches Sales Volume Market Share, 2022
9.7.3 By Type, Japan Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Transdermal Drug Patches Market Size, 2018-2029
9.8.2 By Company, South Korea Transdermal Drug Patches Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Transdermal Drug Patches Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Transdermal Drug Patches Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Transdermal Drug Patches Market Size, 2018-2029
9.10.2 By Company, India Transdermal Drug Patches Sales Volume Market Share, 2022
9.10.3 By Type, India Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Transdermal Drug Patches Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Transdermal Drug Patches Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Transdermal Drug Patches Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Transdermal Drug Patches Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Hisamitsu Pharmaceutical
10.1.1 Hisamitsu Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.1.2 Hisamitsu Pharmaceutical Transdermal Drug Patches Models, Specifications and Application
10.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Hisamitsu Pharmaceutical Company Profile and Main Business
10.1.5 Hisamitsu Pharmaceutical Recent Developments
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
10.2.2 Johnson & Johnson Transdermal Drug Patches Models, Specifications and Application
10.2.3 Johnson & Johnson Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Johnson & Johnson Company Profile and Main Business
10.2.5 Johnson & Johnson Recent Developments
10.3 Mylan
10.3.1 Mylan Company Information, Head Office, Market Area and Industry Position
10.3.2 Mylan Transdermal Drug Patches Models, Specifications and Application
10.3.3 Mylan Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Mylan Company Profile and Main Business
10.3.5 Mylan Recent Developments
10.4 UCB Pharma
10.4.1 UCB Pharma Company Information, Head Office, Market Area and Industry Position
10.4.2 UCB Pharma Transdermal Drug Patches Models, Specifications and Application
10.4.3 UCB Pharma Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 UCB Pharma Company Profile and Main Business
10.4.5 UCB Pharma Recent Developments
10.5 Novartis
10.5.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.5.2 Novartis Transdermal Drug Patches Models, Specifications and Application
10.5.3 Novartis Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Novartis Company Profile and Main Business
10.5.5 Novartis Recent Developments
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.6.2 Teva Pharmaceutical Transdermal Drug Patches Models, Specifications and Application
10.6.3 Teva Pharmaceutical Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Teva Pharmaceutical Company Profile and Main Business
10.6.5 Teva Pharmaceutical Recent Developments
10.7 Beijing Tide Pharmaceutical
10.7.1 Beijing Tide Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.7.2 Beijing Tide Pharmaceutical Transdermal Drug Patches Models, Specifications and Application
10.7.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Beijing Tide Pharmaceutical Company Profile and Main Business
10.7.5 Beijing Tide Pharmaceutical Recent Developments
10.8 Chattem
10.8.1 Chattem Company Information, Head Office, Market Area and Industry Position
10.8.2 Chattem Transdermal Drug Patches Models, Specifications and Application
10.8.3 Chattem Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Chattem Company Profile and Main Business
10.8.5 Chattem Recent Developments
10.9 Nitto Denko
10.9.1 Nitto Denko Company Information, Head Office, Market Area and Industry Position
10.9.2 Nitto Denko Transdermal Drug Patches Models, Specifications and Application
10.9.3 Nitto Denko Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Nitto Denko Company Profile and Main Business
10.9.5 Nitto Denko Recent Developments
10.10 Grünenthal
10.10.1 Grünenthal Company Information, Head Office, Market Area and Industry Position
10.10.2 Grünenthal Transdermal Drug Patches Models, Specifications and Application
10.10.3 Grünenthal Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Grünenthal Company Profile and Main Business
10.10.5 Grünenthal Recent Developments
10.11 Mundipharma
10.11.1 Mundipharma Company Information, Head Office, Market Area and Industry Position
10.11.2 Mundipharma Transdermal Drug Patches Models, Specifications and Application
10.11.3 Mundipharma Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Mundipharma Company Profile and Main Business
10.11.5 Mundipharma Recent Developments
10.12 GSK
10.12.1 GSK Company Information, Head Office, Market Area and Industry Position
10.12.2 GSK Transdermal Drug Patches Models, Specifications and Application
10.12.3 GSK Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 GSK Company Profile and Main Business
10.12.5 GSK Recent Developments
10.13 Luye Pharma Group
10.13.1 Luye Pharma Group Company Information, Head Office, Market Area and Industry Position
10.13.2 Luye Pharma Group Transdermal Drug Patches Models, Specifications and Application
10.13.3 Luye Pharma Group Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Luye Pharma Group Company Profile and Main Business
10.13.5 Luye Pharma Group Recent Developments
10.14 Bayer
10.14.1 Bayer Company Information, Head Office, Market Area and Industry Position
10.14.2 Bayer Transdermal Drug Patches Models, Specifications and Application
10.14.3 Bayer Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Bayer Company Profile and Main Business
10.14.5 Bayer Recent Developments
10.15 IBSA Group
10.15.1 IBSA Group Company Information, Head Office, Market Area and Industry Position
10.15.2 IBSA Group Transdermal Drug Patches Models, Specifications and Application
10.15.3 IBSA Group Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 IBSA Group Company Profile and Main Business
10.15.5 IBSA Group Recent Developments
10.16 Dr Reddy’s Laboratories
10.16.1 Dr Reddy’s Laboratories Company Information, Head Office, Market Area and Industry Position
10.16.2 Dr Reddy’s Laboratories Transdermal Drug Patches Models, Specifications and Application
10.16.3 Dr Reddy’s Laboratories Transdermal Drug Patches Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Dr Reddy’s Laboratories Company Profile and Main Business
10.16.5 Dr Reddy’s Laboratories Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Transdermal Drug Patches Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Transdermal Drug Patches Market Restraints
Table 3. Transdermal Drug Patches Market Trends
Table 4. Transdermal Drug Patches Industry Policy
Table 5. Global Transdermal Drug Patches Revenue by Company, 2018-2023, US$ million
Table 6. Global Transdermal Drug Patches Revenue Market Share by Company, 2018-2023
Table 7. Global Transdermal Drug Patches Sales Volume by Company, 2018-2023, (M Pieces)
Table 8. Global Transdermal Drug Patches Sales Volume Market Share by Company, 2018-2023
Table 9. Global Transdermal Drug Patches Price by Company, 2018-2023, (USD/Piece)
Table 10. Global Transdermal Drug Patches Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Transdermal Drug Patches Mergers & Acquisitions, Expansion Plans
Table 12. Global Transdermal Drug Patches Manufacturers Product Type
Table 13. China Transdermal Drug Patches Revenue by Company, 2018-2023, US$ million
Table 14. China Transdermal Drug Patches Revenue Market Share by Company, 2018-2023
Table 15. China Transdermal Drug Patches Sales Volume by Company, 2018-2023, (M Pieces)
Table 16. China Transdermal Drug Patches Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Transdermal Drug Patches Production, Sales, Import and Export, 2018-2029, (M Pieces)
Table 18. China Transdermal Drug Patches Import & Export Trends
Table 19. Main Sources of China Transdermal Drug Patches Import
Table 20. Export Destination of China Transdermal Drug Patches
Table 21. Global Headquarters and Manufacturing Base of Transdermal Drug Patches Manufacturers
Table 22. Global Major Manufacturers, Transdermal Drug Patches Capacity Expansion and Future Plans
Table 23. Global Transdermal Drug Patches Production & Forecast by Region, 2018 VS 2022 VS 2029, (M Pieces)
Table 24. Global Transdermal Drug Patches Production by Region, 2018-2023, (M Pieces)
Table 25. Global Transdermal Drug Patches Production Forecast by Region, 2023-2029, (M Pieces)
Table 26. Global Key Players of Transdermal Drug Patches Upstream (Raw Materials)
Table 27. Global Transdermal Drug Patches Typical Customers
Table 28. Transdermal Drug Patches Typical Distributors
Table 29. By Type, Global Transdermal Drug Patches Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Transdermal Drug Patches Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Transdermal Drug Patches Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Transdermal Drug Patches Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Transdermal Drug Patches Sales Volume, 2018-2029, (M Pieces)
Table 34. By Country, Global Transdermal Drug Patches Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Transdermal Drug Patches Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Transdermal Drug Patches Revenue Market Share, 2018-2029
Table 37. By Country, Global Transdermal Drug Patches Sales Volume, 2018-2029, (M Pieces)
Table 38. By Country, Global Transdermal Drug Patches Sales Volume Market Share, 2018-2029
Table 39. Hisamitsu Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 40. Hisamitsu Pharmaceutical Transdermal Drug Patches Models, Specifications and Application
Table 41. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 42. Hisamitsu Pharmaceutical Company Profile and Main Business
Table 43. Hisamitsu Pharmaceutical Recent Developments
Table 44. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 45. Johnson & Johnson Transdermal Drug Patches Models, Specifications and Application
Table 46. Johnson & Johnson Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 47. Johnson & Johnson Company Profile and Main Business
Table 48. Johnson & Johnson Recent Developments
Table 49. Mylan Company Information, Head Office, Market Area and Industry Position
Table 50. Mylan Transdermal Drug Patches Models, Specifications and Application
Table 51. Mylan Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 52. Mylan Company Profile and Main Business
Table 53. Mylan Recent Developments
Table 54. UCB Pharma Company Information, Head Office, Market Area and Industry Position
Table 55. UCB Pharma Transdermal Drug Patches Models, Specifications and Application
Table 56. UCB Pharma Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 57. UCB Pharma Company Profile and Main Business
Table 58. UCB Pharma Recent Developments
Table 59. Novartis Company Information, Head Office, Market Area and Industry Position
Table 60. Novartis Transdermal Drug Patches Models, Specifications and Application
Table 61. Novartis Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 62. Novartis Company Profile and Main Business
Table 63. Novartis Recent Developments
Table 64. Teva Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 65. Teva Pharmaceutical Transdermal Drug Patches Models, Specifications and Application
Table 66. Teva Pharmaceutical Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 67. Teva Pharmaceutical Company Profile and Main Business
Table 68. Teva Pharmaceutical Recent Developments
Table 69. Beijing Tide Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 70. Beijing Tide Pharmaceutical Transdermal Drug Patches Models, Specifications and Application
Table 71. Beijing Tide Pharmaceutical Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 72. Beijing Tide Pharmaceutical Company Profile and Main Business
Table 73. Beijing Tide Pharmaceutical Recent Developments
Table 74. Chattem Company Information, Head Office, Market Area and Industry Position
Table 75. Chattem Transdermal Drug Patches Models, Specifications and Application
Table 76. Chattem Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 77. Chattem Company Profile and Main Business
Table 78. Chattem Recent Developments
Table 79. Nitto Denko Company Information, Head Office, Market Area and Industry Position
Table 80. Nitto Denko Transdermal Drug Patches Models, Specifications and Application
Table 81. Nitto Denko Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 82. Nitto Denko Company Profile and Main Business
Table 83. Nitto Denko Recent Developments
Table 84. Grünenthal Company Information, Head Office, Market Area and Industry Position
Table 85. Grünenthal Transdermal Drug Patches Models, Specifications and Application
Table 86. Grünenthal Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 87. Grünenthal Company Profile and Main Business
Table 88. Grünenthal Recent Developments
Table 89. Mundipharma Company Information, Head Office, Market Area and Industry Position
Table 90. Mundipharma Transdermal Drug Patches Models, Specifications and Application
Table 91. Mundipharma Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 92. Mundipharma Company Profile and Main Business
Table 93. Mundipharma Recent Developments
Table 94. GSK Company Information, Head Office, Market Area and Industry Position
Table 95. GSK Transdermal Drug Patches Models, Specifications and Application
Table 96. GSK Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 97. GSK Company Profile and Main Business
Table 98. GSK Recent Developments
Table 99. Luye Pharma Group Company Information, Head Office, Market Area and Industry Position
Table 100. Luye Pharma Group Transdermal Drug Patches Models, Specifications and Application
Table 101. Luye Pharma Group Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 102. Luye Pharma Group Company Profile and Main Business
Table 103. Luye Pharma Group Recent Developments
Table 104. Bayer Company Information, Head Office, Market Area and Industry Position
Table 105. Bayer Transdermal Drug Patches Models, Specifications and Application
Table 106. Bayer Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 107. Bayer Company Profile and Main Business
Table 108. Bayer Recent Developments
Table 109. IBSA Group Company Information, Head Office, Market Area and Industry Position
Table 110. IBSA Group Transdermal Drug Patches Models, Specifications and Application
Table 111. IBSA Group Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 112. IBSA Group Company Profile and Main Business
Table 113. IBSA Group Recent Developments
Table 114. Dr Reddy’s Laboratories Company Information, Head Office, Market Area and Industry Position
Table 115. Dr Reddy’s Laboratories Transdermal Drug Patches Models, Specifications and Application
Table 116. Dr Reddy’s Laboratories Transdermal Drug Patches Sales Volume (M Pieces), Revenue (US$ Million), Price (USD/Piece) and Gross Margin, 2018-2023
Table 117. Dr Reddy’s Laboratories Company Profile and Main Business
Table 118. Dr Reddy’s Laboratories Recent Developments
List of Figure
Figure 1. Transdermal Drug Patches Picture
Figure 2. By Revenue, Global Transdermal Drug Patches Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Transdermal Drug Patches Market Size and Forecast, 2018-2029, (M Pieces)
Figure 4. Global Transdermal Drug Patches Price Trend, 2018-2029, (USD/Piece)
Figure 5. By Revenue, China Transdermal Drug Patches Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Transdermal Drug Patches Market Size and Forecast, 2018-2029, (M Pieces)
Figure 7. China Transdermal Drug Patches Price Trend, 2018-2029 (USD/Piece)
Figure 8. By Revenue, China Transdermal Drug Patches Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Transdermal Drug Patches Share of Global Market, 2018-2029
Figure 10. Global Transdermal Drug Patches Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Transdermal Drug Patches Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Transdermal Drug Patches Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Transdermal Drug Patches Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Transdermal Drug Patches Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Transdermal Drug Patches Domestic VS Export, 2022
Figure 16. Global Transdermal Drug Patches Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Transdermal Drug Patches Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Transdermal Drug Patches Production Market Share & Forecast by Region, 2018-2029
Figure 19. Transdermal Drug Patches Industry Chain
Figure 20. Transdermal Drug Patches Procurement Model
Figure 21. Transdermal Drug Patches Sales Model
Figure 22. Transdermal Drug Patches Sales Channels, Direct Sales and Distribution
Figure 23. Methyl Salicylate-based Patch
Figure 24. Rivastigmine Transdermal Patch
Figure 25. Fentanyl Transdermal Patch
Figure 26. Lidocaine Patch
Figure 27. Diclofenac Patch
Figure 28. Nicotine Transdermal Patch
Figure 29. Others
Figure 30. By Type, Global Transdermal Drug Patches Revenue, 2018-2029, US$ Million
Figure 31. By Type, Global Transdermal Drug Patches Revenue Market Share, 2018-2029
Figure 32. By Type, Global Transdermal Drug Patches Sales Volume, 2018-2029, (M Pieces)
Figure 33. By Type, Global Transdermal Drug Patches Sales Volume Market Share, 2018-2029
Figure 34. By Type, Global Transdermal Drug Patches Price, 2018-2029, (USD/Piece)
Figure 35. Rx Channel
Figure 36. OTC Channel
Figure 37. By Application, Global Transdermal Drug Patches Revenue, 2018-2029, US$ Million
Figure 38. By Application, Global Transdermal Drug Patches Revenue Market Share, 2018-2029
Figure 39. By Application, Global Transdermal Drug Patches Sales Volume, 2018-2029, (M Pieces)
Figure 40. By Application, Global Transdermal Drug Patches Sales Volume Market Share, 2018-2029
Figure 41. By Application, Global Transdermal Drug Patches Price, 2018-2029, (USD/Piece)
Figure 42. By Region, Global Transdermal Drug Patches Revenue Market Share, 2018-2029
Figure 43. By Region, Global Transdermal Drug Patches Sales Volume Market Share, 2018-2029
Figure 44. North America Transdermal Drug Patches Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, North America Transdermal Drug Patches Revenue Market Share, 2022
Figure 46. Europe Transdermal Drug Patches Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, Europe Transdermal Drug Patches Revenue Market Share, 2022
Figure 48. Asia Pacific Transdermal Drug Patches Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country/Region, Asia Pacific Transdermal Drug Patches Revenue Market Share, 2022
Figure 50. South America Transdermal Drug Patches Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. By Country, South America Transdermal Drug Patches Revenue Market Share, 2022
Figure 52. Middle East & Africa Transdermal Drug Patches Revenue & Forecasts, 2018-2029, US$ Million
Figure 53. U.S. Transdermal Drug Patches Sales Volume, 2018-2029, (M Pieces)
Figure 54. By Company, U.S. Transdermal Drug Patches Market Share, 2022
Figure 55. By Type, U.S. Transdermal Drug Patches Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, U.S. Transdermal Drug Patches Sales Volume Market Share, 2022 VS 2029
Figure 57. Europe Transdermal Drug Patches Sales Volume, 2018-2029, (M Pieces)
Figure 58. By Company, Europe Transdermal Drug Patches Market Share, 2022
Figure 59. By Type, Europe Transdermal Drug Patches Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, Europe Transdermal Drug Patches Sales Volume Market Share, 2022 VS 2029
Figure 61. China Transdermal Drug Patches Sales Volume, 2018-2029, (M Pieces)
Figure 62. By Company, China Transdermal Drug Patches Market Share, 2022
Figure 63. By Type, China Transdermal Drug Patches Sales Volume Market Share, 2022 VS 202
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|